TY - JOUR
T1 - Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages
AU - Klocke, Jan
AU - Kopetschke, Katharina
AU - Grießbach, Anna Sophie
AU - Langhans, Valerie
AU - Humrich, Jens Y.
AU - Biesen, Robert
AU - Dragun, Duska
AU - Radbruch, Andreas
AU - Burmester, Gerd Rüdiger
AU - Riemekasten, Gabriela
AU - Enghard, Philipp
N1 - Funding Information:
J.K. and P.E. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study design: J.K., G.R., P.E. Acquisition of data: J.K., K.K., A.S.G., V.L., P.E. Analysis and interpretation of data: J.K., K.K., A.S.G., V.L., J.Y.H., R.B., D.D., A.R., G.R.B., G.R., P.E. Manuscript preparation: J.K., K.K., A.S.G., V.L., J.Y.H., R.B., D.D., A.R., G.R.B., G.R., P.E. All authors read and approved the manuscript. We thank Brad Rovin for helpful discussion and all patients for donating samples. This work was supported by the Deutsche Forschungsgemeinschaft (SFB 650), grants from the University Hospital Charit? Berlin and the Stiftung Charit?, Berlin. The ethics committee of Charit? University Hospital (Charit? EA1/034/10) approved the study. Informed consent was obtained from all patients before participation.
Publisher Copyright:
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Renal infiltration of inflammatory cells contributes to the pathogenesis of lupus nephritis (LN). Current knowledge on the recruitment mechanisms relies mainly on findings in rodent models. Here, we assess various chemokine pathways in human LN by comparing urinary chemokine concentrations (in 25 patients with acute LN and in 78 lupus patients without active LN) with the expression of corresponding chemokine receptors on urinary leukocytes (in ten acute LN patients). Nine urinary chemokines were significantly elevated in LN patients and correlated with renal disease activity and urinary cell counts; however, their concentrations displayed considerable interindividual heterogeneity. Analysis of the corresponding receptors revealed abundance of urinary CD8+ T cells for CCR5 and CXCR3, while CD4+ T cells were additionally enriched for CCR1, CCR6 and CXCR6. Urinary Treg showed similar CCR expression, and urinary CD14+ macrophages were enriched for CCR5 expressing cells. In conclusion, cell specific recruitment patterns seem to involve CCR5 and CXCR3 in all cells studied, while CD4+ T-cell subset recruitment is probably much more varied. However, urinary chemokine abundance in active LN is individually variable in our cohort and does not offer a singular chemokine usable as universal biomarker or potential future treatment target.
AB - Renal infiltration of inflammatory cells contributes to the pathogenesis of lupus nephritis (LN). Current knowledge on the recruitment mechanisms relies mainly on findings in rodent models. Here, we assess various chemokine pathways in human LN by comparing urinary chemokine concentrations (in 25 patients with acute LN and in 78 lupus patients without active LN) with the expression of corresponding chemokine receptors on urinary leukocytes (in ten acute LN patients). Nine urinary chemokines were significantly elevated in LN patients and correlated with renal disease activity and urinary cell counts; however, their concentrations displayed considerable interindividual heterogeneity. Analysis of the corresponding receptors revealed abundance of urinary CD8+ T cells for CCR5 and CXCR3, while CD4+ T cells were additionally enriched for CCR1, CCR6 and CXCR6. Urinary Treg showed similar CCR expression, and urinary CD14+ macrophages were enriched for CCR5 expressing cells. In conclusion, cell specific recruitment patterns seem to involve CCR5 and CXCR3 in all cells studied, while CD4+ T-cell subset recruitment is probably much more varied. However, urinary chemokine abundance in active LN is individually variable in our cohort and does not offer a singular chemokine usable as universal biomarker or potential future treatment target.
UR - http://www.scopus.com/inward/record.url?scp=85006001516&partnerID=8YFLogxK
U2 - 10.1002/eji.201646387
DO - 10.1002/eji.201646387
M3 - Journal articles
C2 - 27753073
AN - SCOPUS:85006001516
SN - 0014-2980
VL - 47
SP - 180
EP - 192
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 1
ER -